Global Humanized Liver Mice Models Industry Market Research 2022-2030
21 Oct 2022
Healthcare & Pharmaceuticals
Impact Analysis on the Growth of Market
Inflation and Looming Recession to Haunt Businesses:
In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022...
The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.
With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.
"In 2021, the global humanized liver mouse model market is anticipated to expand at a CAGR of ~6% over the forecast period 2022-2030. As a promising alternative to traditional animal models. The human liver is a reservoir of several important pathogens, causing more than 500 million infections and 2.5 to 4.5 million deaths each year.
Humanized liver mouse model market at global and regional levels. The report provides an in-depth analysis of the humanized liver mouse model market from 2019 to 2026, with 2019 as the base year and 2020 to 2026 as the forecast period. The 2016-2018 data has been included as historical information.
The study provides a detailed view on market growth throughout the forecast period mentioned above, in terms of revenue estimates (in millions of dollars), in different regions, including North America (NA), Europe (EU), Asia Pacific (APAC), Middle East and Africa (MEA) and South America This report provides qualitative and quantitative information about the trends in the humanized liver mouse model industry, and detailed analysis of the market size and growth rate of all market segments. The global humanized liver mouse model market is segmented by application and region.
Global humanized liver mouse model market dynamics:
The increase in government funding for liver disease treatments increases the number of R&D activities that will drive the global market during the forecast period. They are more powerful tools and have sparked interest in using them as models to answer other questions specific to the liver. Many new genome editing therapies are being developed, among which humanized liver mice provide a unique testing environment for genome editing therapy delivery methods, showing huge market opportunities. Humanized transgenic mice are valuable animal models for understanding the importance of specific human drug-metabolizing enzymes in drug clearance and pharmacokinetics, as well as predicting potential drug-drug interactions and chemical toxicity in humans. The efficacy, toxicology and pharmacokinetic characteristics of candidate drugs for small molecule drugs and biological agents, including host-directed antibodies and pathogenic components. Preclinical evaluation of the efficacy of vaccines in mice transplanted with human tissues can effectively support various pathologies, as well as research on the safety, effectiveness and pharmacokinetics of therapeutic drugs and biological products.
The characteristics of drug metabolism show that the human liver mouse model has shown useful results in predicting human drug interactions and the induction and inhibition of endogenous enzymes. All these reasons provide a global basis for the development of drugs marketed by humanized liver mouse models. Growth opportunities. For example, mice with a human immune system and supplemented human lung tissue can mimic the pathogenesis of tuberculosis or cytomegalovirus (CMV).
Regional insight :
Into the global humanized liver mouse model market: The implementation of high research facilities and research facilities in research institutions, especially in the field of life sciences, is expected to expand the global market for humanized liver mouse models. The humanized liver mouse model develops the global market in European economies. The development of a new genetically modified human liver model with advanced technology is a key development and has a positive impact on the global humanized liver mouse model.
In the global humanized liver mouse model market • Jackson Laboratory • Crown Bioscience Inc. • Charles River Laboratories International Inc. • Taconic Biosciences Inc. • Ingenious Targeting Laboratory Inc. • Trans Genic Inc. Ltd. • GenOway • Creative Animodel • Horizon Exploration Group Co., Ltd. • Hera BioLabs • PhoenixBio Group • Beijing Vinda Biotechnology Co., Ltd. • Yecuris Corporation"
The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:
- North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys & Opportunity Outlook
- Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook